Investigating the effect of Bupivacaine on post operative pain after rhinoplasty
Phase 3
Recruiting
- Conditions
- patients underwent rhinoplasty.Encounter for plastic and reconstructive surgery following medical procedure or healed injury
- Registration Number
- IRCT20131020015083N5
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
ASA I physical status based on the American Classification of Anesthesiology (ASA)
Age between 17 and 50 years
Performing primary rhinoplasty with standard technique and oblique lateral-medial osteotomy
Exclusion Criteria
Not agreeing to participate in the study
Patients with cardiovascular disease
History of sensitivity to bupivacaine
Receiving other anesthetics before and during the operation
Cognitive disorders and the inability to communicate and express the level of pain
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Degree of nasal pain. Timepoint: 1 hour after the operation, 6 hours after the operation, 1 day after the operation, 2 days after the operation and 3 days after the operation. Method of measurement: Visual analog scale (VAS).;Analgesic consumption. Timepoint: 1 hour after the operation, 6 hours after the operation, 1 day after the operation, 2 days after the operation and 3 days after the operation. Method of measurement: Asking the patient directly and recording analgesic consumption.
- Secondary Outcome Measures
Name Time Method ausea-vomiting. Timepoint: 1 hour after the operation, 6 hours after the operation, 1 day after the operation, 2 days after the operation and 3 days after the operation. Method of measurement: Visual analog scale.;Postoperative complications. Timepoint: up to 7 days. Method of measurement: direct physical examination.